☰

Aldemar B. Degroot, Ph.D. - Publications

Affiliations: 
University of Alberta, Edmonton, Alberta, Canada 
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Balcer OM, Seager MA, Gleason SD, Li X, Rasmussen K, Maxwell JK, Nomikos G, Degroot A, Witkin JM. Evaluation of 5-HT receptor antagonism for the treatment of anxiety, depression, and schizophrenia through the use of receptor-deficient mice. Behavioural Brain Research. 360: 270-278. PMID 30543903 DOI: 10.1016/J.Bbr.2018.12.019  0.302
2005 Degroot A, Nomikos GG. Fluoxetine disrupts the integration of anxiety and aversive memories. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 391-400. PMID 15592351 DOI: 10.1038/sj.npp.1300624  0.395
2004 Degroot A, Nomikos GG. Genetic deletion and pharmacological blockade of CB1 receptors modulates anxiety in the shock-probe burying test. The European Journal of Neuroscience. 20: 1059-64. PMID 15305874 DOI: 10.1111/j.1460-9568.2004.03556.x  0.465
2004 Degroot A, Wade M, Salhoff C, Davis RJ, Tzavara ET, Nomikos GG. Exposure to an elevated platform increases plasma corticosterone and hippocampal acetylcholine in the rat: reversal by chlordiazepoxide. European Journal of Pharmacology. 493: 103-9. PMID 15189770 DOI: 10.1016/j.ejphar.2004.04.011  0.339
2004 Degroot A, Treit D. Anxiety is functionally segregated within the septo-hippocampal system. Brain Research. 1001: 60-71. PMID 14972654 DOI: 10.1016/J.Brainres.2003.10.065  0.656
2003 Degroot A, Kornecook T, Quirion R, DeBow S, Parent MB. Glucose increases hippocampal extracellular acetylcholine levels upon activation of septal GABA receptors. Brain Research. 979: 71-7. PMID 12850573 DOI: 10.1016/S0006-8993(03)02868-3  0.433
2003 Degroot A, Treit D. Septal GABAergic and hippocampal cholinergic systems interact in the modulation of anxiety. Neuroscience. 117: 493-501. PMID 12614689 DOI: 10.1016/S0306-4522(02)00651-6  0.667
2002 Degroot A, Treit D. Dorsal and ventral hippocampal cholinergic systems modulate anxiety in the plus-maze and shock-probe tests. Brain Research. 949: 60-70. PMID 12213300 DOI: 10.1016/S0006-8993(02)02965-7  0.682
2001 Degroot A, Parent MB. Infusions of physostigmine into the hippocampus or the entorhinal cortex attenuate avoidance retention deficits produced by intra-septal infusions of the GABA agonist muscimol. Brain Research. 920: 10-8. PMID 11716806 DOI: 10.1016/S0006-8993(01)02798-6  0.465
2001 Degroot A, Kashluba S, Treit D. Septal GABAergic and hippocampal cholinergic systems modulate anxiety in the plus-maze and shock-probe tests. Pharmacology, Biochemistry, and Behavior. 69: 391-9. PMID 11509196 DOI: 10.1016/S0091-3057(01)00541-X  0.69
2001 Treit D, Degroot A, kashluba S, Bartoszyk GD. Systemic EMD 68843 injections reduce anxiety in the shock-probe, but not the plus-maze test. European Journal of Pharmacology. 414: 245-8. PMID 11239925 DOI: 10.1016/S0014-2999(01)00799-3  0.596
2000 Degroot A, Parent MB. Increasing acetylcholine levels in the hippocampus or entorhinal cortex reverses the impairing effects of septal GABA receptor activation on spontaneous alternation. Learning & Memory (Cold Spring Harbor, N.Y.). 7: 293-302. PMID 11040261 DOI: 10.1101/Lm.32200  0.51
Show low-probability matches.